SCHEMBL5087356

SCHEMBL5087356

CCOC(=O)Nc1ccc(OCc2ccccc2OC(F)(F)F)cc1N

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNQ2 O43526 4/20 0.45
KCNQ3 O43525 3/20 0.45
KCNQ4 P56696 1/20 0.45
KCNQ5 Q9NR82 1/20 0.45
PARP10 Q53GL7 2/20 0.45
PARP14 Q460N5 1/20 0.45
LNPEP Q9UIQ6 1/20 0.43
HSD17B13 Q7Z5P4 1/20 0.41
SMN1; SMN2 Q16637 2/20 0.40
MAPT P10636 2/20 0.40
NPSR1 Q6W5P4 2/20 0.40
CYP1A2 P05177 2/20 0.40
CYP2C9 P11712 2/20 0.40
CYP2C19 P33261 2/20 0.40
LMNA P02545 1/20 0.40
GAA P10253 1/20 0.40
TSHR P16473 1/20 0.40
HDAC3 O15379 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC2 Q92769 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5087381 0.86 MAOB (0.51) KCNQ2KCNQ3KCNQ4KCNQ5LNPEP
SCHEMBL5089271 0.85 PARP10 (0.50) KCNQ2KCNQ3KCNQ4KCNQ5PARP10
SCHEMBL5090936 0.84 MAOB (0.48) KCNQ2KCNQ3KCNQ4KCNQ5SMN1; SMN2
SCHEMBL5096507 0.80 KCNQ2 (0.54) KCNQ2KCNQ3KCNQ4KCNQ5SMN1; SMN2
SCHEMBL5090320 0.80 ALDH1A1 (0.53) KCNQ2KCNQ3KCNQ4KCNQ5LNPEP
SCHEMBL5090811 0.78 KCNQ2 (0.65) KCNQ2KCNQ3KCNQ4KCNQ5PARP10
SCHEMBL14097681 0.78 CYP1A2 (0.56) KCNQ2KCNQ3KCNQ4KCNQ5SMN1; SMN2
SCHEMBL5095940 0.78 KCNQ2 (0.52) KCNQ2KCNQ3KCNQ4KCNQ5PARP10
SCHEMBL5087380 0.77 KCNQ2 (0.57) KCNQ2KCNQ3KCNQ4KCNQ5CYP1A2
SCHEMBL5087179 0.77 MAOB (0.54) KCNQ2KCNQ3MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8722929-B2 N-[2-amino-4-(phenylmethoxy)phenyl] amides and related compounds as potassium channel modulators VALEANT PHARMACEUTICALS INTERNATIONAL (US) 2014-05-13 US disclosed
US-20080188561-A1 N-[2-AMINO-4-(PHENYLMETHOXY)PHENYL] AMIDES AND RELATED COMPOUNDS AS POTASSIUM CHANNEL MODULATORS JPMORGAN CHASE BANK, N.A. 2008-08-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080188561-A1 N-[2-AMINO-4-(PHENYLMETHOXY)PHENYL] AMIDES AND RELATED COMPOUNDS AS POTASSIUM CHANNEL MODULATORS KCNB2, KCNJ2, KCNA2 KCNQ2 9/4885KCNQ3 32/4885KCNQ4 26/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.